Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes
dc.contributor.author | Savage, P | en_US |
dc.contributor.author | Cowburn, P | en_US |
dc.contributor.author | Clayton, A | en_US |
dc.contributor.author | Man, S | en_US |
dc.contributor.author | McMichael, A | en_US |
dc.contributor.author | Lemoine, N | en_US |
dc.contributor.author | Epenetos, A | en_US |
dc.contributor.author | Ogg, G | en_US |
dc.date.accessioned | 2015-04-13T12:54:07Z | |
dc.date.available | 2002-01-28 | en_US |
dc.date.issued | 2002-04-22 | en_US |
dc.identifier.issn | 0007-0920 | en_US |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375334/ | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/7223 | |
dc.format.extent | 1336 - 1342 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | BRIT J CANCER | en_US |
dc.subject | cancer | en_US |
dc.subject | immunctherapy | en_US |
dc.subject | HLA class I | en_US |
dc.subject | vaccines | en_US |
dc.subject | B cells | en_US |
dc.subject | CD20 | en_US |
dc.subject | CYTOTOXIC T-LYMPHOCYTES | en_US |
dc.subject | PULSED DENDRITIC CELLS | en_US |
dc.subject | EPSTEIN-BARR VIRUS | en_US |
dc.subject | MELANOMA PATIENTS | en_US |
dc.subject | VITRO INDUCTION | en_US |
dc.subject | FUSION PROTEIN | en_US |
dc.subject | ANTIGENS | en_US |
dc.subject | ACTIVATION | en_US |
dc.subject | VIVO | en_US |
dc.subject | IMMUNOTHERAPY | en_US |
dc.title | Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1038/sj/bjc/6600223 | en_US |
pubs.issue | 8 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 86 | en_US |